We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why Investors Should Retain Molina Healthcare (MOH) Stock
Read MoreHide Full Article
Molina Healthcare, Inc.’s (MOH - Free Report) consistent operating performance is backed by its steady increase in premiums and service revenues, effective inorganic growth initiatives and solid fundamentals. Well reflective of the tailwinds, year to date, shares of Molina Healthcare gained 28%, outperforming the Zacks categorized Medical-Health Maintenance Organization industry’s gain of 19%.
Molina Healthcare witnessed a steady increase in premiums and service revenues over the past several quarters. More care intensive benefits and higher premiums associated with the aged, blind or disabled and Medicare members substantially contributed to the increased revenues.
Molina Healthcare has been growing via in-market or tuck-in acquisitions over last few years. This not only contributed considerably to the company’s growth in existing markets but also helped in establishing its footprint across the globe. In 2016, the company completed its acquisition of Universal American’s Total Care Medicaid plan.
In addition, Molina Healthcare’s s steadily growing operating cash flow helped it in deploying capital in the most effective manner. Continuing the trend, net cash from operating activities totaled $719 million in the first quarter of 2017, up 417% over the year-ago quarter.
However, the company’s earnings continue to be challenged by rising medical care costs. The rise stemmed from higher utilization, physician and outpatient costs. Influenza-related illnesses and costs associated with the more recently enrolled members were the key factors in higher utilization. Medical care costs have spiked dramatically at an eight-year CAGR of 23.95%.
Moreover, Molina Healthcare’s over dependence on debt financing led to a rise in interest expenses that again pose risks of draining the bottom line. High level of debt can also hurt the company’s face value.
Align Technology, a medical dental supplies company, topped estimates in each of the last four quarters with an average beat of 59.23%.
Inogen is a medical instruments seller, which delivered positive surprises in each of the last four quarters with an average beat of 82.42%.
EDAP TMS also posted positive surprises in two of the last four quarters with an average beat of 366.67%.
Zacks' Hidden Trades
While we share many recommendations and ideas with the public, certain moves are hidden from everyone but selected members of our portfolio services. Would you like to peek behind the curtain today and view them?
Starting now, for the next month, I invite you to follow all Zacks' private buys and sells in real time from value to momentum...from stocks under $10 to ETF to option movers...from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors.
Image: Bigstock
Why Investors Should Retain Molina Healthcare (MOH) Stock
Molina Healthcare, Inc.’s (MOH - Free Report) consistent operating performance is backed by its steady increase in premiums and service revenues, effective inorganic growth initiatives and solid fundamentals. Well reflective of the tailwinds, year to date, shares of Molina Healthcare gained 28%, outperforming the Zacks categorized Medical-Health Maintenance Organization industry’s gain of 19%.
Molina Healthcare witnessed a steady increase in premiums and service revenues over the past several quarters. More care intensive benefits and higher premiums associated with the aged, blind or disabled and Medicare members substantially contributed to the increased revenues.
Molina Healthcare has been growing via in-market or tuck-in acquisitions over last few years. This not only contributed considerably to the company’s growth in existing markets but also helped in establishing its footprint across the globe. In 2016, the company completed its acquisition of Universal American’s Total Care Medicaid plan.
In addition, Molina Healthcare’s s steadily growing operating cash flow helped it in deploying capital in the most effective manner. Continuing the trend, net cash from operating activities totaled $719 million in the first quarter of 2017, up 417% over the year-ago quarter.
However, the company’s earnings continue to be challenged by rising medical care costs. The rise stemmed from higher utilization, physician and outpatient costs. Influenza-related illnesses and costs associated with the more recently enrolled members were the key factors in higher utilization. Medical care costs have spiked dramatically at an eight-year CAGR of 23.95%.
Moreover, Molina Healthcare’s over dependence on debt financing led to a rise in interest expenses that again pose risks of draining the bottom line. High level of debt can also hurt the company’s face value.
Zacks Rank and Stocks to Consider
Molina Healthcare presently has a Zacks Rank #3 (Hold). Investors can consider some better-ranked stocks like Align Technology, Inc. (ALGN - Free Report) , EDAP TMS S.A. (EDAP - Free Report) and Inogen Inc. (INGN - Free Report) . All of the stocks sport a Zacks Rank #1(Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Align Technology, a medical dental supplies company, topped estimates in each of the last four quarters with an average beat of 59.23%.
Inogen is a medical instruments seller, which delivered positive surprises in each of the last four quarters with an average beat of 82.42%.
EDAP TMS also posted positive surprises in two of the last four quarters with an average beat of 366.67%.
Zacks' Hidden Trades
While we share many recommendations and ideas with the public, certain moves are hidden from everyone but selected members of our portfolio services. Would you like to peek behind the curtain today and view them?
Starting now, for the next month, I invite you to follow all Zacks' private buys and sells in real time from value to momentum...from stocks under $10 to ETF to option movers...from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors.
Click here for Zacks' secret trade>>